These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9260793)

  • 21. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C.
    Ikura Y; Morimoto H; Johmura H; Fukui M; Sakurai M
    Am J Gastroenterol; 1996 Jul; 91(7):1367-73. PubMed ID: 8677997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.
    Lecube A; Hernández C; Simó R
    Diabetes Metab Res Rev; 2009 Jul; 25(5):403-10. PubMed ID: 19444865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia.
    Giardini C; Galimberti M; Lucarelli G; Polchi P; Angelucci E; Baronciani D; Erer B; Gaziev D; Piga A; Di Gregorio F; Romeo MA; Mangiagli A; Petrelli E; Muretto P
    Bone Marrow Transplant; 1997 Nov; 20(9):767-72. PubMed ID: 9384479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus.
    Sebastiani G; Tempesta D; Alberti A
    J Viral Hepat; 2012 Feb; 19(2):e170-6. PubMed ID: 22239515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
    Umemura T; Alter HJ; Tanaka E; Orii K; Yeo AE; Shih JW; Matsumoto A; Yoshizawa K; Kiyosawa K
    Hepatology; 2002 Apr; 35(4):953-9. PubMed ID: 11915044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors predicting interferon treatment response in patients with chronic hepatitis c: late viral clearance does not preclude a sustained response.
    Ebeling F; Lappalainen M; Vuoristo M; Nuutinen H; Leino R; Karvonen AL; Lehtola J; Julkunen R; Pohjanpelto P; Färkkilä M
    Am J Gastroenterol; 2001 Apr; 96(4):1237-42. PubMed ID: 11316176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
    Fontana RJ; Israel J; LeClair P; Banner BF; Tortorelli K; Grace N; Levine RA; Fiarman G; Thiim M; Tavill AS; Bonkovsky HL
    Hepatology; 2000 Mar; 31(3):730-6. PubMed ID: 10706565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron depletion and response to interferon in chronic hepatitis C.
    Carlo C; Daniela P; Giancarlo C
    Hepatogastroenterology; 2003; 50(53):1467-71. PubMed ID: 14571765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
    Girelli CM; Mirata C; Casiraghi A
    Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron in hepatitis C: villain or innocent bystander?
    Ioannou GN; Tung BY; Kowdley KV
    Semin Gastrointest Dis; 2002 Apr; 13(2):95-108. PubMed ID: 12064865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
    Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
    Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey.
    Shan Y; Lambrecht RW; Bonkovsky HL
    Clin Infect Dis; 2005 Mar; 40(6):834-41. PubMed ID: 15736017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of hepatitis C: re-treatment with alpha interferon.
    Alberti A; Chemello L; Noventa F; Cavalletto L; De Salvo G
    Hepatology; 1997 Sep; 26(3 Suppl 1):137S-142S. PubMed ID: 9305679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron.
    Hayashi H; Takikawa T; Nishimura N; Yano M; Isomura T; Sakamoto N
    Am J Gastroenterol; 1994 Jul; 89(7):986-8. PubMed ID: 8017395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver disease in adult transfusion-dependent beta-thalassaemic patients: investigating the role of iron overload and chronic HCV infection.
    Kountouras D; Tsagarakis NJ; Fatourou E; Dalagiorgos E; Chrysanthos N; Berdoussi H; Vgontza N; Karagiorga M; Lagiandreou A; Kaligeros K; Voskaridou E; Roussou P; Diamanti-Kandarakis E; Koskinas J
    Liver Int; 2013 Mar; 33(3):420-7. PubMed ID: 23402611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection.
    Arber N; Moshkowitz M; Konikoff F; Halpern Z; Hallak A; Santo M; Tiomny E; Baratz M; Gilat T
    Dig Dis Sci; 1995 Nov; 40(11):2431-3. PubMed ID: 7587826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.